ARCHIVES

NCI Names 15 to Director’s Consumer Liaison Group.

This article is from The Cancer Letter archive.

Vol. 31 No. 02 | January 14, 2005

Download PDF Visit The Full Archive

Related Articles

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

NCAB Subcommittee Tells Califano To Keep Hands Off Board Appointments

May 18, 1979

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

As von Eschenbach Prepares For New Assignment, NCI’s 2015 Goal Faces Uncertainty. New Strategic Plan Lists Steps to 2015. “The Vision Is Within Our Grasp,” von Eschenbach Says.

March 10, 2006